Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges and opportunities in the development of complex generic long-acting injectable drug products
Matthew N. O’Brien, Wenlei Jiang, Yan Wang, et al.
Journal of Controlled Release (2021) Vol. 336, pp. 144-158
Closed Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Machine learning models to accelerate the design of polymeric long-acting injectables
Pauric Bannigan, Zeqing Bao, Riley J. Hickman, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 109
Delivering on the promise of protein degraders
Matthew N. O’Brien, Suman Luthra, Matthew F. Brown, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 5, pp. 410-427
Closed Access | Times Cited: 58
Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management
Baljinder Singh, Candace M. Day, Sadikalmahdi Abdella, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 402-424
Open Access | Times Cited: 53
Challenges and Complications of Poly(lactic-co-glycolic acid)-Based Long-Acting Drug Product Development
Yi Wen Lim, Wen Siang Tan, Kok Lian Ho, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 614-614
Open Access | Times Cited: 68
Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate
Behjat Sheikholeslami, Nga Wing Lam, Kamal Dua, et al.
Life Sciences (2022) Vol. 300, pp. 120574-120574
Closed Access | Times Cited: 63
Current trends in PLGA based long-acting injectable products: The industry perspective
Omkara Swami Muddineti, Abdelwahab Omri
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 5, pp. 559-576
Closed Access | Times Cited: 43
Recent advances in lipid-based long-acting injectable depot formulations
Reena Sharma, Sheetal Yadav, Vivek R. Yadav, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114901-114901
Closed Access | Times Cited: 34
Microstructure Formation and Characterization of Long-Acting Injectable Microspheres: The Gateway to Fully Controlled Drug Release Pattern
Mengdi Wang, Shan Wang, Changhao Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1571-1595
Open Access | Times Cited: 12
Patient-Centric Long-Acting Injectable and Implantable Platforms─An Industrial Perspective
Simone Alidori, Raju Subramanian, René Holm
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4238-4258
Open Access | Times Cited: 10
ROS‐Responsive Microneedle Patches Enable Peri‐Lacrimal Gland Therapeutic Administration for Long‐Acting Therapy of Sjögren's Syndrome‐Related Dry Eye
Jingqing Mu, Xiangyu Ding, Yapeng Song, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
BioJect: An in vitro platform to explore release dynamics of peptides in subcutaneous drug delivery
David Li, Qin Qiuhua, Ayça Altay Benetti, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 1058-1079
Closed Access | Times Cited: 1
Complex Peptide Injectables: Development and Challenges
Anjaneyulu Vinukonda, Kishore Rapolu, Rajendra Kumar Jadi, et al.
International Journal of Peptide Research and Therapeutics (2025) Vol. 31, Iss. 3
Closed Access | Times Cited: 1
Lipid based intramuscular long-acting injectables: Current state of the art
Janine M. Wilkinson, Damilola Ajulo, Valeria Tamburrini, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 178, pp. 106253-106253
Open Access | Times Cited: 36
Long-acting injectable formulation technologies: challenges and opportunities for the delivery of fragile molecules
Andrea Gonella, Sylvestre Grizot, Fang Liu, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 8, pp. 927-944
Open Access | Times Cited: 33
Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent
Raju Subramanian, Jennifer Tang, Jim Zheng, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 12, pp. 6213-6225
Open Access | Times Cited: 22
Long acting injectables for the treatment of prostate cancer
Dimple Modi, Md Sadique Hussain, Swetha Ainampudi, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 105996-105996
Closed Access | Times Cited: 8
Effect of particle size on in vivo performances of long-acting injectable drug suspension
Myoung Jin Ho, Min Young Jeong, Hoe Taek Jeong, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 533-547
Closed Access | Times Cited: 38
Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities
C. Bassand, Alessia Villois, Lucas Gianola, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 10, pp. 1265-1283
Closed Access | Times Cited: 27
An expanding horizon of complex injectable products: development and regulatory considerations
Kanan Panchal, Sumeet Katke, Sanat Kumar Dash, et al.
Drug Delivery and Translational Research (2022) Vol. 13, Iss. 2, pp. 433-472
Open Access | Times Cited: 24
The Management of Parkinson’s Disease: An Overview of the Current Advancements in Drug Delivery Systems
Deepa D. Nakmode, Candace M. Day, Yunmei Song, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1503-1503
Open Access | Times Cited: 16
Comparison of in vivo behaviors of intramuscularly long-acting celecoxib nanosuspensions with different particle sizes for the postoperative pain treatment
Mengdi Qin, Genyang Ye, Jinghan Xin, et al.
International Journal of Pharmaceutics (2023) Vol. 636, pp. 122793-122793
Closed Access | Times Cited: 14
Complex ophthalmic formulation technologies: Advancement and future perspectives
Vaibhavi Srivastava, Padakanti Sandeep Chary, Naveen Rajana, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104317-104317
Closed Access | Times Cited: 14
Long-Acting Injectable Antipsychotics—A Review on Formulation and In Vitro Dissolution
Magdalena Markowicz-Piasecka, Marcin Kubisiak, Katarzyna Asendrych-Wicik, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 28-28
Open Access | Times Cited: 14
Bottom-up production of injectable itraconazole suspensions using membrane technology
Fatima Anjum, Thaïsa Viville, Snehashis Nandi, et al.
International Journal of Pharmaceutics (2024) Vol. 654, pp. 123977-123977
Open Access | Times Cited: 5
Development and approval of novel injectables: enhancing therapeutic innovations
Pooja Yadav, Yuvraj Singh, Divya Chauhan, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 639-662
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top